483 Novartis Pharma AG Jul 2017

483 Novartis Pharma AG Jul 2017

$119 - Not in Stock

FDA investigators audited the Novartis Pharma AG - Basel, Switzerland facility and issued inspectional observations (via FDA 483) on 06 Jul 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 06 Jul 2017
  • Location: Basel, Switzerland
  • FEI: 3002807772

Pre-Order Not Available